BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 852469)

  • 1. Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
    Driessen O; Höppener R
    Eur Neurol; 1977; 15(3):135-42. PubMed ID: 852469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy.
    Bäckström T; Jorpes P
    Acta Neurol Scand; 1979 Mar; 59(2-3):63-71. PubMed ID: 452841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
    Watanabe S; Kuyama C; Yokoyama S; Kubo S; Iwai H
    Folia Psychiatr Neurol Jpn; 1977; 31(2):205-17. PubMed ID: 903037
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Drug levels in epilepsy.
    Lancet; 1975 Aug; 2(7928):264-7. PubMed ID: 49804
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical and theoretical aspects of phenytoin administration. I. Relationship between dose and plasma concentration.
    Driessen O; Höppener RJ; van der Velde EA
    Eur Neurol; 1980; 19(6):353-65. PubMed ID: 7439208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of phenytoin and phenobarbital in epileptic patients treated with mixture antiepileptic tablets, Comital-L or Hydantol-F.
    Kazamatsuri H; Hattori M
    Folia Psychiatr Neurol Jpn; 1979; 33(3):319-22. PubMed ID: 520947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. A study of the clinical effects.
    Volanschi D; Pintilie C
    Neurol Psychiatr (Bucur); 1978; 16(4):259-69. PubMed ID: 741196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum concentrations of phenobarbital and fenitoin in the ambulatory treatment of epileptic patients].
    Pascu I; Popoviciu L; Iazigian A; Gondaş M; Micu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1979; 24(4):277-80. PubMed ID: 531392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ethnic differences in serum phenytoin levels].
    Dam M; Hübbe P; Christiansen J
    Ugeskr Laeger; 1974 Aug; 136(35):1974-6. PubMed ID: 4848674
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of carbamazepine combinations in epilepsy.
    Cereghino JJ; Brock JT; Van Meter JC; Penry JK; Smith LD; White BG
    Clin Pharmacol Ther; 1975 Dec; 18(6):733-41. PubMed ID: 1106934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
    Schmidt D; Einicke I; Haenel F
    Arch Neurol; 1986 Mar; 43(3):263-5. PubMed ID: 3947275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtherapeutic levels of phenytoin with standard doses in infants: need to review dosage schedule.
    Rane CT; Gogtay NJ; Kadam VS; Powar HS; Dalvi SS; Kshirsagar NA
    Br J Clin Pharmacol; 1999 Sep; 48(3):465-6. PubMed ID: 10576792
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
    Schmidt D; Haenel F
    Neurology; 1984 Sep; 34(9):1252-5. PubMed ID: 6540414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of anticonvulsant drug therapy in epileptic patients assessed by plasma level analyses.
    Wilson JT; Wilkinson GR
    Neurology; 1974 Jul; 24(7):614-23. PubMed ID: 4858085
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of dose, age, and sex on the serum levels of phenobarbital and diphenylhydantoin in epileptic patients.
    Furlanut M; Benetello P; Testa G; Da Ronch A
    Pharmacol Res Commun; 1978 Jan; 10(1):85-9. PubMed ID: 643894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.